OTCM
DIZTF
Market cap17mUSD
Jun 24, Last price
0.22USD
Name
Dignitana AB
Chart & Performance
P/E
—
P/S
1.93
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.28%
Rev. gr., 5y
17.16%
Revenues
90m
+4.38%
Net income
-19m
L+10.46%
CFO
373k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dignitana AB (publ) is a medical technology firm that designs, manufactures, and sells specialized medical cooling equipment to markets across the United States and globally. Its primary product, DigniCap, is a unique scalp cooling system engineered to help prevent hair loss in patients receiving particular chemotherapy treatments, specifically those battling breast cancer. The company, which established its operations in 2007, is based in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||